Aptose Biosciences Inc at Jefferies Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. My name is Megan Dorogi. I'm an Analyst in Jefferies Healthcare Investment Banking. It is my pleasure to introduce Bill Rice, President, Chairman and CEO of Aptose Biosciences, to present at our virtual health care conference.
So without further ado, I will hand it over to Bill.
Good afternoon. Thank you, Megan, for giving us the opportunity to present at the Jefferies Healthcare Conference. So first, I'll remind everyone that today, I will make certain forward-looking statements. Also, today's presentation is intended more toward providing an introduction to a new audience because many of the investors who follow us are aware that next week we plan to release all of our new clinical data as part of the European Hematology Association, or EHA Conference.
So for those of you who are new to the story, Aptose is a clinical stage biotech company, and we develop small molecule targeted agents for the treatment of life-threatening hematologic
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
